openPR Logo
Press release

OTC Drug and Dietary Supplement Market Expected to Witness a Sustainable Growth over 2024

09-05-2017 05:23 PM CET | Health & Medicine

Press release from: Transparency Market Research

OTC Drug and Dietary Supplement Market Expected to Witness

Global OTC Drug and Dietary Supplement Market: Overview 

Over the past few years, the market for over-the-counter (OTC) drugs and dietary supplements has witnessed rapid growth. The increasing prevalence of self-medication for the treatment of primary health conditions and the growing demand for dietary supplements in daily consumption have provided momentum to the growth of the OTC drugs and dietary supplement market. Development of strong regulatory policies governing the sale of OTC drugs and the focus of manufacturers to adhere to higher quality standard and correct branding and labeling of dietary supplements have intensified their interest in the marketing of these products. All these factors are anticipated to give impetus to the market across the globe. 

Request Sample Copy of the Report @http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=100
The research report is prepared with extensive inputs from a wide range of market participants that include business executives, product managers, clinical specialists, healthcare organizations, and leading trade associations. The report provides in-depth analysis of the current and emerging trends, key drivers and restraining factors, changes in regulatory landscape and their impact on competitive dynamics, and strategies adopted by the leading market players. The study tracks recent developments in drug making and key R&D activities undertaken by pharmaceutical companies making dietary supplements. The report provides insights into labeling and branding strategies of manufacturers that conform to various regulatory environments in major regions. A wide array of graphical data corroborated by SWOT analysis of major end-use industry segments are also covered in the study.

Global OTC Drug and Dietary Supplement Market: Trends and Opportunities

The growth in the OTC drugs and dietary supplement market is driven by the growing awareness on general health concerns and advancements in pharmaceutical industry. The rising trend among people to opt for OTC drugs for a range of minor ailments without doctor consultation and proliferation of information available in different media regarding the functions of dietary supplements have fuelled the growth of the market in major regions. Vast range of youth population seeking medical counsel over the Internet has propelled the demand for OTC drugs and dietary supplements. 

Request TOC of the Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=100
Stringent regulations by the FDA regarding the safety and efficacy testing of OTC drugs have delayed their approval. In addition, the continued monitoring about the health claims of the dietary supplements by regulatory agencies and regulatory requirements for correct rebranding are likely to impede the market’s growth. However, R&D activities undertaken by market players to offer enhanced OTC drugs for the treatment of a range of ailments, such as heartburn remedies, laxatives, oral antiseptics, anti-smoking products, nutrition aids, and analgesics, are expected to create vast opportunities for the market players.  

Global OTC Drug and Dietary Supplement Market: Regional Outlook 

The Americas is a prominent market for OTC drug and dietary supplements. Growth in the region is driven by the increasing sale of OTC gastrointestinal drugs and wide preference for non-prescription drugs over prescription drugs in various countries such as Mexico and Brazil. In addition, robust healthcare practices and the initiatives to control burgeoning healthcare costs have boosted the regional market.

Global OTC Drug and Dietary Supplement Market: Competitive Landscape

Prominent players operating in the market include Pfizer, Novartis, Sun Pharma, Proctor and Gamble, GlaxoSmithKline, and Bayer AG. Leading companies launch new products and adopt mergers and acquisitions as the key strategy to consolidate their market shares.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Drug and Dietary Supplement Market Expected to Witness a Sustainable Growth over 2024 here

News-ID: 699195 • Views:

More Releases from Transparency Market Research

Paper-based Biofuel Cell Market to Reach USD 580.0 Mn by 2034, Driven by Rising Adoption of Wearable Electronics and Healthcare Applications |TMR
Paper-based Biofuel Cell Market to Reach USD 580.0 Mn by 2034, Driven by Rising …
The global Paper-based Biofuel Cell (PBFC) market is poised for substantial growth over the next decade, with its market value projected to rise from US$ 300.0 million in 2023 to US$ 580.0 million by 2034, reflecting a CAGR of 6.3% during the forecast period 2024-2034. The market is witnessing increased traction due to the expanding adoption of wearable electronic devices, rising prevalence of lifestyle diseases, and ongoing technological innovations in
Parcel Sortation System Market Projected to Reach USD 3.1 Billion by 2034, Driven by Surge in E-Commerce and Adoption of Automated Sorting Robots | TMR
Parcel Sortation System Market Projected to Reach USD 3.1 Billion by 2034, Drive …
The global Parcel Sortation System Market is witnessing steady growth, fueled by the rapid expansion of e-commerce, the rise in online shopping, and increasing adoption of automated parcel sorting robots. Valued at US$ 2.2 billion in 2023, the market is projected to reach US$ 3.1 billion by 2034, expanding at a CAGR of 3.1% during the forecast period from 2024 to 2034. Gain a preview of important insights from our Report
Paresthesia Treatment Market Forecast to Reach USD 8.0 Billion by 2034, Growing at a CAGR of 3.7% | TMR
Paresthesia Treatment Market Forecast to Reach USD 8.0 Billion by 2034, Growing …
The global Paresthesia Treatment Market is poised for steady growth over the forecast period 2024-2034, driven by rising incidence of neurological disorders, technological advancements in treatment modalities, and increasing awareness regarding early diagnosis and intervention. According to the latest industry analysis, the global paresthesia treatment market was valued at US$ 5.4 billion in 2023 and is projected to reach US$ 8.0 billion by 2034, expanding at a CAGR of 3.7%. Gain
Paroxysmal Nocturnal Hemoglobinuria Market Projected to Reach USD 11.7 Billion by 2034, Driven by Biologics and Geriatric Population Growth | TMR
Paroxysmal Nocturnal Hemoglobinuria Market Projected to Reach USD 11.7 Billion b …
The global Paroxysmal Nocturnal Hemoglobinuria (PNH) Market is poised for robust growth over the coming decade. Valued at US$ 3.8 billion in 2023, the market is projected to expand at a CAGR of 10.8% from 2024 to 2034, reaching US$ 11.7 billion by the end of 2034. The rise in geriatric population, coupled with the influx of biologics and advances in therapeutic strategies, is propelling the demand for effective management

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to